[Kinetic criteria of the effectiveness of treatment of chronic myeloleukosis].
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001966:Bromine / Q000627:therapeutic use; D002066:Busulfan / Q000627:therapeutic use; D006801:Humans; D007951:Leukemia, Myeloid / Q000097:blood / Q000188:drug therapy / Q000532:radiotherapy / Q000628:therapy*; D007958:Leukocyte Count; D008353:Mannitol / Q000627:therapeutic use; D009588:Nitrogen Mustard Compounds / Q000627:therapeutic use; D013223:Statistics as Topic; D014498:Uracil / Q000627:therapeutic use; D014520:Urethane / Q000627:therapeutic use
D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D014520:Urethane; D008353:Mannitol; D014498:Uracil; D002066:Busulfan; D001966:Bromine
Kineticheskie kriterii éffektivnosti lecheniia khronicheskogo mieloleĭkoza.